Tdspharm Co., Ltd. (KOSDAQ:464280)

Tdspharm Statistics

Total Valuation

Tdspharm has a market cap or net worth of KRW 53.70 billion. The enterprise value is 29.95 billion.

Market Cap	53.70B
Enterprise Value	29.95B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Tdspharm has 5.53 million shares outstanding. The number of shares has increased by 20.96% in one year.

Current Share Class	5.53M
Shares Outstanding	5.53M
Shares Change (YoY)	+20.96%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	46.04%
Owned by Institutions (%)	4.27%
Float	2.96M

Valuation Ratios

The trailing PE ratio is 15.65.

PE Ratio	15.65
Forward PE	n/a
PS Ratio	2.19
PB Ratio	1.30
P/TBV Ratio	1.31
P/FCF Ratio	60.01
P/OCF Ratio	25.54
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.45, with an EV/FCF ratio of 33.47.

EV / Earnings	9.13
EV / Sales	1.22
EV / EBITDA	9.45
EV / EBIT	12.23
EV / FCF	33.47

Financial Position

The company has a current ratio of 3.82, with a Debt / Equity ratio of 0.16.

Current Ratio	3.82
Quick Ratio	3.54
Debt / Equity	0.16
Debt / EBITDA	2.04
Debt / FCF	7.21
Interest Coverage	10.53

Financial Efficiency

Return on equity (ROE) is 8.30% and return on invested capital (ROIC) is 3.31%.

Return on Equity (ROE)	8.30%
Return on Assets (ROA)	3.01%
Return on Invested Capital (ROIC)	3.31%
Return on Capital Employed (ROCE)	5.93%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.48
Inventory Turnover	5.82

Taxes

In the past 12 months, Tdspharm has paid 371.34 million in taxes.

Income Tax	371.34M
Effective Tax Rate	10.17%

Stock Price Statistics

The stock price has decreased by -36.12% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-36.12%
50-Day Moving Average	9,457.60
200-Day Moving Average	11,208.80
Relative Strength Index (RSI)	54.53
Average Volume (20 Days)	90,075

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Tdspharm had revenue of KRW 24.56 billion and earned 3.28 billion in profits. Earnings per share was 620.57.

Revenue	24.56B
Gross Profit	6.45B
Operating Income	2.45B
Pretax Income	3.65B
Net Income	3.28B
EBITDA	3.17B
EBIT	2.45B
Earnings Per Share (EPS)	620.57

Balance Sheet

The company has 30.20 billion in cash and 6.45 billion in debt, giving a net cash position of 23.75 billion or 4,294.68 per share.

Cash & Cash Equivalents	30.20B
Total Debt	6.45B
Net Cash	23.75B
Net Cash Per Share	4,294.68
Equity (Book Value)	41.19B
Book Value Per Share	7,786.03
Working Capital	28.79B

Cash Flow

In the last 12 months, operating cash flow was 2.10 billion and capital expenditures -1.21 billion, giving a free cash flow of 894.85 million.

Operating Cash Flow	2.10B
Capital Expenditures	-1.21B
Free Cash Flow	894.85M
FCF Per Share	161.82

Margins

Gross margin is 26.27%, with operating and profit margins of 9.97% and 13.36%.

Gross Margin	26.27%
Operating Margin	9.97%
Pretax Margin	14.87%
Profit Margin	13.36%
EBITDA Margin	12.90%
EBIT Margin	9.97%
FCF Margin	3.64%

Dividends & Yields

Tdspharm does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.96%
Shareholder Yield	-20.96%
Earnings Yield	6.11%
FCF Yield	1.67%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Tdspharm has an Altman Z-Score of 6.3 and a Piotroski F-Score of 4.

Altman Z-Score	6.3
Piotroski F-Score	4